Items without sitelinks

From determinar.ia.br - Determine suas informações

Showing below up to 50 results in range #5,751 to #5,800.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Other parasympathomimetics (Q107064)
  2. Harmful effects of mineral salts, not elsewhere classified (Q107063)
  3. Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Other parasympatholytics or spasmolytics (Q107062)
  4. Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Anticholinesterase agents (Q107061)
  5. Harmful effects of Bisphosphonates (Q107060)
  6. Harmful effects of other diuretics (Q107059)
  7. Harmful effects of drugs affecting uric acid metabolism (Q107058)
  8. Harmful effects of agents primarily affecting water-balance and mineral or uric acid metabolism, Vitamin D and derivatives (Q107057)
  9. Harmful effects of Carbonic-anhydrase inhibitors (Q107056)
  10. Harmful effects of electrolytic, caloric or water-balance agents (Q107055)
  11. Harmful effects of Benzothiadiazine derivatives (Q107054)
  12. Harmful effects of Loop diuretics (Q107053)
  13. Harmful effects of Mineralocorticoids antagonists (Q107052)
  14. Harmful effects of etodolac (Q107051)
  15. Harmful effects of cloral derivatives (Q107050)
  16. Harmful effects of Mineralocorticoids (Q107049)
  17. Harmful effects of promazine (Q107048)
  18. Harmful effects of mixed sedatives or hypnotics, not elsewhere classified (Q107047)
  19. Harmful effects of paraldehyde (Q107046)
  20. Harmful effects of bromine compounds (Q107045)
  21. Harmful effects of anaesthetics or therapeutic gases, intravenous anaesthetics (Q107044)
  22. Pelger-Huet anomaly (Q107043)
  23. Harmful effects of barbiturates (Q107042)
  24. Harmful effects of benzodiazepines (Q107041)
  25. May-Hegglin anomaly (Q107040)
  26. Harmful effects of anaesthetics or therapeutic gases, other inhaled anaesthetics (Q107039)
  27. Harmful effects of anaesthetics or therapeutic gases, local anaesthetics (Q107038)
  28. Harmful effects of anaesthetics or therapeutic gases, nitrous oxide (Q107037)
  29. Harmful effects of anaesthetics or therapeutic gases, gamma hydroxybutyrate (Q107036)
  30. Harmful effects of anaesthetics or therapeutic gases, ketamine (Q107035)
  31. Persistent polyclonal lymphocytosis (Q107034)
  32. Harmful effects of anaesthetics or therapeutic gases, other specified general anaesthetic (Q107033)
  33. Harmful effects of anaesthetics or therapeutic gases, unspecified general anaesthetics (Q107032)
  34. Chronic hepatitis C, co-infected with human immunodeficiency virus, with cirrhosis, without complications of cirrhosis (Q107031)
  35. Alder-Reilly anomaly (Q107030)
  36. Cholecystenteric fistula, not elsewhere classified (Q107029)
  37. Chronic hepatitis C, co-infected with human immunodeficiency virus, with cirrhosis, with complications of cirrhosis (Q107028)
  38. Cholecystocolonic fistula (Q107027)
  39. Papulonecrotic tuberculid (Q107026)
  40. Chorea due to Lesch-Nyhan Syndrome (Q107025)
  41. Chorea due to organic acidaemias (Q107024)
  42. Lichen scrofulosorum (Q107023)
  43. Diplogonoporus grandis infection (Q107022)
  44. Infection by larvae of multiceps (Q107021)
  45. Bertielliasis (Q107020)
  46. Raillietiniasis (Q107019)
  47. Coenurosis (Q107018)
  48. Intraabdominal vitelline cyst or remnants (Q107017)
  49. Umbilical cord vein anomalies, group III (Q107016)
  50. Umbilical cord vein anomalies, group IV (Q107015)

View ( | ) (20 | 50 | 100 | 250 | 500)